Home
Faculty
Podcasts
Webcasts
FAQ Video Module
Journal Club Videos Module
Medical Review Videos Module
Publications
Digital Sponsors
Subscribe
X
Full Name
Email Address
Provider Type
Select Category
MD
DO
PA
NP
RN
MA
Dietician
Other
This field is required.
Subscribe
Reset
Journal Club Videos Module
Journal Club Videos Module
Category
Gastroenterology
Hepatology
General
Biosimilars
Sort by
Oldest
Newest
Journal Club: Review of Focused Recommendations for the Management of MASLD by APPs in the US
Week 48 Efficacy of Guselkumab vs. Ustekinumab in Crohn’s Disease: Insights from GALAXI 2 & 3
Efficacy & Safety of Subcutaneous Guselkumab: 48-Week Results from the Phase 3 GRAVITI Study
Efficacy and Safety of Guselkumab in Ulcerative Colitis: Phase 3 QUASAR Maintenance Study Results
Guselkumab Efficacy & Safety in Moderate to Severe CD-GALAXI 2 & 3 Results
Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Download the app and start using it now
Download on the
App Store
GET IT ON
Google Play
X
Install our app for the best experience!
Install Now
Home 
Faculty 
Podcasts 
Webcasts 
FAQ Video Module 
Journal Club Videos Module 
Medical Review Videos Module 
Publications 
Digital Sponsors 
.png)
